Emcure Pharmaceuticals

1,171.35
-58.10
(-4.73%)
Market Cap
22,189.10
Eps
27.54
PE Ratio (TTM)
40.43
Dividend Yield
0.16
Industry
Healthcare
52 Week High
1,580.00
52 Week low
1,205.95
PB Ratio
5.63
Debt to Equity
0.86
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Emcure Pharmaceuticals Inaugurates Advanced R&D Centre in Gujarat5 days ago
Emcure Pharmaceuticals has inaugurated a state-of-the-art Research and Development (R&D) centre in Gujarat. This new facility is aimed at advancing cutting-edge research in complex drug delivery systems. The establishment of this world-class R&D centre demonstrates Emcure's commitment to innovation and strengthening its capabilities in pharmaceutical research.
Growth Rate
Revenue Growth
11.33 %
Net Income Growth
-6.09 %
Cash Flow Change
46.92 %
ROE
-20.28 %
ROCE
-20.23 %
EBITDA Margin (Avg.)
-5.80 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
4,274
4,812
5,131
5,067
5,919
6,032
6,715
7,356
Expenses
3,461
3,968
4,345
3,817
4,526
4,805
5,429
5,941
EBITDA
813
844
786
1,250
1,393
1,227
1,287
1,415
Operating Profit %
18 %
16 %
14 %
24 %
23 %
20 %
18 %
18 %
Depreciation
228
267
321
250
245
260
312
366
Interest
176
223
257
155
176
214
237
231
Profit Before Tax
291
331
105
841
973
747
727
819
Tax
116
121
5
233
270
185
200
224
Net Profit
174
209
101
607
703
562
528
595
EPS in ₹
9.68
10.79
4.62
21.68
36.62
29.42
27.54
30.80

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
5,247
5,644
6,004
6,807
6,064
6,673
7,806
Fixed Assets
2,049
2,247
2,382
2,188
2,044
2,147
3,125
Current Assets
2,335
2,453
2,703
3,718
3,424
3,836
4,260
Capital Work in Progress
531
581
485
302
320
411
159
Investments
0
0
0
0
25
25
318
Other Assets
2,667
2,817
3,137
4,318
3,674
4,089
4,204
Total Liabilities
5,247
5,644
6,004
6,807
6,064
6,673
7,806
Current Liabilities
2,336
2,543
2,920
3,408
2,965
3,019
3,211
Non Current Liabilities
1,157
1,201
1,100
1,031
985
1,004
1,474
Total Equity
1,755
1,900
1,984
2,368
2,114
2,650
3,122
Reserve & Surplus
1,520
1,654
1,731
2,092
1,807
2,320
2,771
Share Capital
181
181
181
181
181
181
181

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
-700
32
259
42
134
219
Investing Activities
-409
-168
-257
-575
-468
-715
Operating Activities
444
500
704
768
747
1,097
Financing Activities
-735
-301
-189
-152
-145
-164

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Promoter
78.08 %
78.08 %
77.94 %
FIIs
1.76 %
2.91 %
3.05 %
DIIs
3.34 %
3.96 %
3.87 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
7.73 %
5.00 %
5.14 %
No of Share Holders
4,98,006
1,52,914
1,43,449

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,705.50 4,09,206.58 38.22 49,887.20 12.06 9,648 27.34 34.79
5,410.20 1,43,623.81 80.60 8,184.00 0.89 1,600 46.55 30.72
1,420.60 1,12,751.00 24.42 26,520.70 14.17 4,155 47.38 39.95
3,314.80 1,12,187.89 60.63 10,785.70 11.59 1,656 13.54 53.49
2,456.70 1,01,355.31 49.70 10,615.60 19.57 1,942 -16.38 38.34
1,181.25 98,564.79 18.60 28,905.40 12.36 5,578 1.69 23.79
2,022.35 92,259.11 36.10 20,141.50 19.94 1,936 73.53 32.95
910.25 91,592.45 21.70 19,831.50 13.82 3,831 14.57 33.91
1,138.60 66,130.07 18.88 29,559.20 17.55 3,169 8.66 36.75
4,916.05 58,778.75 27.24 12,978.40 9.84 1,812 14.16 25.91

Corporate Action

Technical Indicators

RSI(14)
Neutral
25.61
ATR(14)
Volatile
55.74
STOCH(9,6)
Neutral
25.66
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-21.56
ADX(14)
Weak Trend
23.98
UO(9)
Bearish
36.49
ROC(12)
Downtrend But Slowing Down
-13.74
WillR(14)
Oversold
-83.01